Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Publications

Search Items: DRUG ADMINISTRATION SCHEDULE - , . hits: 153

2018

Aygören-Pürsün, E; Bygum, A; Grivcheva-Panovska, V; Magerl, M; Graff, J; Steiner, UC; Fain, O; Huissoon, A; Kinaciyan, T; Farkas, H; Lleonart, R; Longhurst, HJ; Rae, W; Triggiani, M; Aberer, W; Cancian, M; Zanichelli, A; Smith, WB; Baeza, ML; Du-Thanh, A; Gompels, M; Gonzalez-Quevedo, T; Greve, J; Guilarte, M; Katelaris, C; Dobo, S; Cornpropst, M; Clemons, D; Fang, L; Collis, P; Sheridan, W; Maurer, M; Cicardi, M Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema.
NEW ENGL J MED. 2018; 379(4): 352-362. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Brozek, W; Reichardt, B; Zwerina, J; Dimai, HP; Klaushofer, K; Zwettler, E Use of proton pump inhibitors and mortality after hip fracture in a nationwide study.
Osteoporos Int. 2017; 28(5):1587-1595 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fahrleitner-Pammer, A; Papaioannou, N; Gielen, E; Feudjo Tepie, M; Toffis, C; Frieling, I; Geusens, P; Makras, P; Boschitsch, E; Callens, J; Anastasilakis, AD; Niedhart, C; Resch, H; Kalouche-Khalil, L; Hadji, P Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium.
Arch Osteoporos. 2017; 12(1):58-58 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Fung, P; Bedogni, G; Bedogni, A; Petrie, A; Porter, S; Campisi, G; Bagan, J; Fusco, V; Saia, G; Acham, S; Musto, P; Petrucci, MT; Diz, P; Colella, G; Mignogna, MD; Pentenero, M; Arduino, P; Lodi, G; Maiorana, C; Manfredi, M; Hallberg, P; Wadelius, M; Takaoka, K; Leung, YY; Bonacina, R; Schiødt, M; Lakatos, P; Taylor, T; De Riu, G; Favini, G; Rogers, SN; Pirmohamed, M; Nicoletti, P; GENVABO Consortium; Fedele, S Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study.
Oral Dis. 2017; 23(4):477-483 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Holman, RR; Bethel, MA; Mentz, RJ; Thompson, VP; Lokhnygina, Y; Buse, JB; Chan, JC; Choi, J; Gustavson, SM; Iqbal, N; Maggioni, AP; Marso, SP; Öhman, P; Pagidipati, NJ; Poulter, N; Ramachandran, A; Zinman, B; Hernandez, AF; EXSCEL Study Group Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
N Engl J Med. 2017; 377(13): 1228-1239. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mueller, RB; Graninger, W; Sidiropoulos, P; Goger, C; von Kempis, J Median time to low disease activity is shorter in tocilizumab combination therapy with csDMARDs as compared to tocilizumab monotherapy in patients with active rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: sub-analysis of the Swiss and Austrian patients from the ACT-SURE study.
Clin Rheumatol. 2017; 36(10):2187-2192
Web of Science PubMed FullText FullText_MUG

 

Palkovits, S; Seidel, G; Pertl, L; Malle, EM; Hausberger, S; Makk, J; Singer, C; Osterholt, J; Herzog, SA; Haas, A; Weger, M MACULAR CHOROIDAL VOLUME CHANGES AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
Retina. 2017; 37(12):2262-2268
Web of Science PubMed FullText FullText_MUG

 

Pölzl, G; Altenberger, J; Baholli, L; Beltrán, P; Borbély, A; Comin-Colet, J; Delgado, JF; Fedele, F; Fontana, A; Fruhwald, F; Giamouzis, G; Giannakoulas, G; Garcia-González, MJ; Gustafsson, F; Kaikkonen, K; Kivikko, M; Kubica, J; von Lewinski, D; Löfman, I; Malfatto, G; Manito, N; Martínez-Sellés, M; Masip, J; Merkely, B; Morandi, F; Mølgaard, H; Oliva, F; Pantev, E; Papp, Z; Perna, GP; Pfister, R; Piazza, V; Bover, R; Rangel-Sousa, D; Recio-Mayoral, A; Reinecke, A; Rieth, A; Sarapohja, T; Schmidt, G; Seidel, M; Störk, S; Vrtovec, B; Wikström, G; Yerly, P; Pollesello, P Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy.
Int J Cardiol. 2017; 243(3):389-395 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Sezer, O; Beksac, M; Hajek, R; Sucak, G; Cagirgan, S; Linkesch, W; Meltem Akay, O; Gülbas, Z; Nahi, H; Plesner, T; Snowden, JA; Timurağaoğlu, A; Dechow, T; Lang, A; Tuğlular, T; Drach, J; Armbrecht, G; Potamianou, A; Couturier, C; Olie, RA; Feys, C; Allietta, N; Terpos, E Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.
Br J Haematol. 2017; 178(1):61-71
Web of Science PubMed FullText FullText_MUG

 

Sticherling, M; Franke, A; Aberer, E; Gläser, R; Hertl, M; Pfeiffer, C; Rzany, B; Schneider, S; Shimanovich, I; Werfel, T; Wilczek, A; Zillikens, D; Schmidt, E An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone.
Br J Dermatol. 2017; 177(5):1299-1305
Web of Science PubMed FullText FullText_MUG

 

2016

Abrahamian, H; Kautzky-Willer, A; Rießland-Seifert, A; Fasching, P; Ebenbichler, C; Hofmann, P; Toplak, H [Mental disorders and diabetes mellitus].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S170-S178 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Bethel, MA; Harrison, P; Sourij, H; Sun, Y; Tucker, L; Kennedy, I; White, S; Hill, L; Oulhaj, A; Coleman, RL; Holman, RR Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes.
Diabet Med. 2016; 33(2):224-230
Web of Science PubMed FullText FullText_MUG

 

Blevins, T; Pieber, TR; Colón Vega, G; Zhang, S; Bastyr, EJ; Chang, AM; IMAGINE 4 Investigators Randomized double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 2 diabetes: IMAGINE 4.
Diabetes Obes Metab. 2016; 18(11):1072-1080 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Buttgereit, F; Dejaco, C; Matteson, EL; Dasgupta, B Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
JAMA. 2016; 315(22):2442-2458
Web of Science PubMed FullText FullText_MUG

 

Clodi, M; Abrahamian, H; Drexel, H; Fasching, P; Föger, B; Francesconi, C; Hoppichler, F; Kaser, S; Kautzky-Willer, A; Lechleitner, M; Ludvik, B; Prager, R; Fröhlich-Reiterer, E; Roden, M; Säly, C; Schernthaner, G; Sourij, H; Toplak, H; Wascher, TC; Weitgasser, R [Antihyperglycemic treatment guidelines for diabetes mellitus type 2].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S45-S53 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fabian, E; Bordag, N; Herold, M; Kamp, H; Krennrich, G; Looser, R; Ma-Hock, L; Mellert, W; Montoya, G; Peter, E; Prokudin, A; Spitzer, M; Strauss, V; Walk, T; Zbranek, R; van Ravenzwaay, B Metabolite profiles of rats in repeated dose toxicological studies after oral and inhalative exposure.
Toxicol Lett. 2016; 255: 11-23.
Web of Science PubMed FullText FullText_MUG

 

Goldinger, SM; Gobbi Bischof, S; Fink-Puches, R; Klemke, CD; Dréno, B; Bagot, M; Dummer, R Efficacy and Safety of APO866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma: A Phase 2 Clinical Trial.
JAMA Dermatol. 2016; 152(7):837-839 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Heise, T; Korsatko, S; Nosek, L; Coester, HV; Deller, S; Roepstorff, C; Segel, S; Kapur, R; Haahr, H; Hompesch, M Steady state is reached within 2-3 days of once-daily administration of degludec, a basal insulin with an ultralong duration of action.
J Diabetes. 2016; 8(1):132-138
Web of Science PubMed FullText FullText_MUG

 

Holman, RR; Bethel, MA; George, J; Sourij, H; Doran, Z; Keenan, J; Khurmi, NS; Mentz, RJ; Oulhaj, A; Buse, JB; Chan, JC; Iqbal, N; Kundu, S; Maggioni, AP; Marso, SP; Öhman, P; Pencina, MJ; Poulter, N; Porter, LE; Ramachandran, A; Zinman, B; Hernandez, AF Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial.
Am Heart J. 2016; 174(6):103-110 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Klamroth, R; Simpson, M; von Depka-Prondzinski, M; Gill, JC; Morfini, M; Powell, JS; Santagostino, E; Davis, J; Huth-Kühne, A; Leissinger, C; Neumeister, P; Bensen-Kennedy, D; Feussner, A; Limsakun, T; Zhou, M; Veldman, A; St Ledger, K; Blackman, N; Pabinger, I Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate(®) ) in patients with severe haemophilia A.
Haemophilia. 2016; 22(5):730-738 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Moinzadeh, P; Riemekasten, G; Siegert, E; Fierlbeck, G; Henes, J; Blank, N; Melchers, I; Mueller-Ladner, U; Frerix, M; Kreuter, A; Tigges, C; Lahner, N; Susok, L; Guenther, C; Zeidler, G; Pfeiffer, C; Worm, M; Karrer, S; Aberer, E; Bretterklieber, A; Genth, E; Simon, JC; Distler, JH; Hein, R; Schneider, M; Seitz, CS; Herink, C; Steinbrink, K; Sárdy, M; Varga, R; Mensing, H; Mensing, C; Lehmann, P; Neeck, G; Fiehn, C; Weber, M; Goebeler, M; Burkhardt, H; Buslau, M; Ahmadi-Simab, K; Himsel, A; Juche, A; Koetter, I; Kuhn, A; Sticherling, M; Hellmich, M; Kuhr, K; Krieg, T; Ehrchen, J; Sunderkoetter, C; Hunzelmann, N; German Network for Systemic Scleroderma Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients.
J Rheumatol. 2016; 43(1):66-74 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Novacek, G; Dejaco, C; Gröchenig, HP; Högenauer, C; Knoflach, P; Miehsler, W; Moschen, A; Petritsch, W; Vogelsang, H; Tilg, H [In Process Citation].
Z Gastroenterol. 2016; 54(5):456-467
Web of Science PubMed FullText FullText_MUG

 

Radda, S; Bolz, M; Egger, S; Gasser-Steiner, V; Kralinger, M; Mennel, S; Scholda, C; Stolba, U; Wedrich, A; Krepler, K [Diagnosis, treatment and monitoring of diabetic eye control].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S97-102 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rami-Merhar, B; Fröhlich-Reiterer, E; Hofer, SE Diabetes in the youth].
Wien Klin Wochenschr. 2016; 128 Suppl 2(3):S119-S123 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rodbard, HW; Cariou, B; Pieber, TR; Endahl, LA; Zacho, J; Cooper, JG Treatment intensification with an insulin degludec (IDeg)/insulin aspart (IAsp) co-formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomized, controlled phase III trial.
Diabetes Obes Metab. 2016; 18(3):274-280 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schernthaner, G; Drexel, H; Rosenkranz, A; Schernthaner, GH; Watschinger, B Antihypertensive therapy in diabetes mellitus: Guidelines of the Austrian Diabetes Association 2016].
Wien Klin Wochenschr. 2016; 128 Suppl 2(21):S62-S67 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Stadler, M; Zlamal-Fortunat, S; Schütz-Fuhrmann, I; Rami-Merhar, B; Fröhlich-Reiterer, E; Hofer, S; Mader, J; Resl, M; Kautzky-Willer, A; Weitgasser, R; Prager, R; Bischof, M [Insulin pump therapy in children, adolescents and adults].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S188-S195 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Toplak, H; Hoppichler, F; Wascher, TC; Schindler, K; Ludvik, B [Obesity and type 2 diabetes].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S196-S200 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wascher, TC; Paulweber, B; Toplak, H; Säly, CH; Drexel, H; Föger, B; Hoppichler, F [Lipids--Diagnosis and therapy in diabetes mellitus].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S68-S70 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Weiss, TW; Aichinger, J; Huber, K; Speidl, WS; Watzinger, N; Zweiker, R; Alber, HF Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction.
Wien Klin Wochenschr. 2016; 128(11-12):450-457 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Dejaco, C; Singh, YP; Perel, P; Hutchings, A; Camellino, D; Mackie, S; Abril, A; Bachta, A; Balint, P; Barraclough, K; Bianconi, L; Buttgereit, F; Carsons, S; Ching, D; Cid, M; Cimmino, M; Diamantopoulos, A; Docken, W; Duftner, C; Fashanu, B; Gilbert, K; Hildreth, P; Hollywood, J; Jayne, D; Lima, M; Maharaj, A; Mallen, C; Martinez-Taboada, V; Maz, M; Merry, S; Miller, J; Mori, S; Neill, L; Nordborg, E; Nott, J; Padbury, H; Pease, C; Salvarani, C; Schirmer, M; Schmidt, W; Spiera, R; Tronnier, D; Wagner, A; Whitlock, M; Matteson, EL; Dasgupta, B; European League Against Rheumatism; American College of Rheumatology 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
Ann Rheum Dis. 2015; 74(10):1799-1807 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Dejaco, C; Singh, YP; Perel, P; Hutchings, A; Camellino, D; Mackie, S; Matteson, EL; Dasgupta, B Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica.
Ann Rheum Dis. 2015; 74(10):1808-1817 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hadji, P; Papaioannou, N; Gielen, E; Feudjo Tepie, M; Zhang, E; Frieling, I; Geusens, P; Makras, P; Resch, H; Möller, G; Kalouche-Khalil, L; Fahrleitner-Pammer, A Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
Osteoporos Int. 2015; 26(10):2479-2489 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hilbe, W; Pall, G; Kocher, F; Pircher, A; Zabernigg, A; Schmid, T; Schumacher, M; Jamnig, H; Fiegl, M; Gächter, A; Freund, M; Kendler, D; Manzl, C; Zelger, B; Popper, H; Wöll, E Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study).
PLoS One. 2015; 10(5):e0125364-e0125364 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Longhurst, HJ; Aberer, W; Bouillet, L; Caballero, T; Fabien, V; Zanichelli, A; Maurer, M; IOS Investigators Analysis of characteristics associated with reinjection of icatibant: Results from the icatibant outcome survey.
Allergy Asthma Proc. 2015; 36(5):399-406
Web of Science PubMed FullText FullText_MUG

 

Marovt, M; El Shabrawi-Caelen, L Purpuric bullous pemphigoid.
Am J Dermatopathol. 2015; 37(2):e18-e20 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Nellis, G; Metsvaht, T; Varendi, H; Toompere, K; Lass, J; Mesek, I; Nunn, AJ; Turner, MA; Lutsar, I; ESNEE consortium Potentially harmful excipients in neonatal medicines: a pan-European observational study.
Arch Dis Child. 2015; 100(7): 694-699.
Web of Science PubMed FullText FullText_MUG

 

Neubauer, KM; Mader, JK; Höll, B; Aberer, F; Donsa, K; Augustin, T; Schaupp, L; Spat, S; Beck, P; Fruhwald, FM; Schnedl, C; Rosenkranz, AR; Lumenta, DB; Kamolz, LP; Plank, J; Pieber, TR Standardized Glycemic Management with a Computerized Workflow and Decision Support System for Hospitalized Patients with Type 2 Diabetes on Different Wards.
Diabetes Technol Ther. 2015; 17(10):685-692 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Wenzl, HH; Primas, C; Novacek, G; Teml, A; Öfferlbauer-Ernst, A; Högenauer, C; Vogelsang, H; Petritsch, W; Reinisch, W Withdrawal of long-term maintenance treatment with azathioprine tends to increase relapse risk in patients with Crohn's disease.
Dig Dis Sci. 2015; 60(5):1414-1423
Web of Science PubMed FullText FullText_MUG

 

Zani, A; Eaton, S; Puri, P; Rintala, R; Lukac, M; Bagolan, P; Kuebler, JF; Hoellwarth, ME; Wijnen, R; Tovar, J; Pierro, A; EUPSA Network International survey on the management of necrotizing enterocolitis.
Eur J Pediatr Surg. 2015; 25(1):27-33 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Hofstetter, B; Gamsjaeger, S; Varga, F; Dobnig, H; Stepan, JJ; Petto, H; Pavo, I; Klaushofer, K; Paschalis, EP Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy.
Osteoporos Int. 2014; 25(12):2709-2719
Web of Science PubMed FullText FullText_MUG

 

Hutterer, M; Nowosielski, M; Haybaeck, J; Embacher, S; Stockhammer, F; Gotwald, T; Holzner, B; Capper, D; Preusser, M; Marosi, C; Oberndorfer, S; Moik, M; Buchroithner, J; Seiz, M; Tuettenberg, J; Herrlinger, U; Wick, A; Vajkoczy, P; Stockhammer, G A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).
Neuro Oncol. 2014; 16(1):92-102 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Koehler, G; Treiber, G; Wutte, A; Korsatko, S; Mader, JK; Semlitsch, B; Pieber, TR Pharmacodynamics of the long-acting insulin analogues detemir and glargine following single-doses and under steady-state conditions in patients with type 1 diabetes.
Diabetes Obes Metab. 2014; 16(1):57-62
Web of Science PubMed FullText FullText_MUG

 

Mader, JK; Lilly, LC; Aberer, F; Korsatko, S; Strock, E; Mazze, RS; Damsbo, P; Pieber, TR A feasibility study of a 3-day basal-bolus insulin delivery device in individuals with type 2 diabetes.
Diabetes Care. 2014; 37(5):1476-1479 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Moazedi-Fuerst, FC; Kielhauser, SM; Brickmann, K; Hermann, J; Lutfi, A; Meilinger, M; Brezinschek, HP; Graninger, WB Rituximab for systemic sclerosis: arrest of pulmonary disease progression in five cases. Results of a lower dosage and shorter interval regimen.
Scand J Rheumatol. 2014; 43(3):257-258 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Piaserico, S; Cazzaniga, S; Chimenti, S; Giannetti, A; Maccarone, M; Picardo, M; Peserico, A; Naldi, L; Psocare Study Group Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the Italian Psocare registry.
J Am Acad Dermatol. 2014; 70(2):257-262 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pronai, W; Neyer, U; Barnas, U; Wieser, C; Jaeger, C; Dekic, D; Hemetsberger, M; Rosenkranz, AR Darbepoetin alfa once every 2 weeks effectively maintained hemoglobin in dialysis patients in an observational study: Austrian cohort of ALTERNATE.
Wien Med Wochenschr. 2014; 164(5-6): 109-119.
PubMed FullText FullText_MUG

 

Rabitsch, W; Böhm, A; Bojic, M; Schellongowski, P; Wöhrer, S; Sliwa, T; Keil, F; Worel, N; Greinix, H; Hauswirth, A; Kalhs, P; Jaeger, U; Valent, P; Sperr, WR Clofarabine/cyclophosphamide for debulking before stem cell transplantation.
Eur J Clin Invest. 2014; 44(8):775-783
Web of Science PubMed FullText FullText_MUG

 

Spiliopoulos, S; Guersoy, D; Koerfer, R; Tenderich, G B-type natriuretic peptide therapy in total artificial heart implantation: renal effects with early initiation.
J Heart Lung Transplant. 2014; 33(6): 662-663.
Web of Science PubMed FullText FullText_MUG

 

Weide, B; Eigentler, TK; Pflugfelder, A; Zelba, H; Martens, A; Pawelec, G; Giovannoni, L; Ruffini, PA; Elia, G; Neri, D; Gutzmer, R; Becker, JC; Garbe, C Intralesional treatment of stage III metastatic melanoma patients with L19-IL2 results in sustained clinical and systemic immunologic responses.
Cancer Immunol Res. 2014; 2(7):668-678 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Show the next 50 results of search
© Meduni GrazImprint